SARCOLEMMAL EXPRESSION OF DYSTROPHIN C-TERMINUS BUT REDUCED EXPRESSION OF 6Q-DYSTROPHIN-RELATED PROTEIN IN 2 DMD PATIENTS WITH LARGE DELETIONS OF THE DYSTROPHIN GENE
Re. Bittner et al., SARCOLEMMAL EXPRESSION OF DYSTROPHIN C-TERMINUS BUT REDUCED EXPRESSION OF 6Q-DYSTROPHIN-RELATED PROTEIN IN 2 DMD PATIENTS WITH LARGE DELETIONS OF THE DYSTROPHIN GENE, Neuromuscular disorders, 5(2), 1995, pp. 81-92
Partial deletions of the dystrophin gene are the predominant genetic l
esions in Duchenne (DMD) and Becker (BMD) muscular dystrophies. Accord
ing to the reading frame hypothesis [1], any deletion disrupting the t
ranslational reading frame of the mRNA cannot result in expression of
the dystrophin molecule and should lead to severe phenotypes of DMD. I
n contrast, deletions which maintain the reading frame across the dele
ted exons may give rise to truncated, semifunctional proteins and mild
er courses of the disease (i.e. BMD). Among the notable exceptions of
this hypothesis are very large ''in-frame'' deletions by which functio
nally indispensable domains of the dystrophin molecule have been remov
ed. Here, we report on two DMD patients with large intragenic in-frame
deletions. Grossly truncated, but stable dystrophin molecules with pr
eserved C-terminal domains were detected at the sarcolemma on cryosect
ions in both patients. However, dystrophin organization on single-teas
ed muscle fibers revealed disarrangement of the costameric pattern, if
compared to normal skeletal muscle fibers. Compared to dystrophin-def
icient DMD muscle. expression of chromosome-6-encoded dystrophin-relat
ed protein (DRP) was greatly diminished in skeletal muscle of both pat
ients. We show, that loss of more than 50% of dystrophin seems to be d
eleterious for the protein's function and therefore, the extent of the
deletions may have an impact on construction of dystrophin mini genes
. Moreover, these findings shed new light on the functional significan
ce of the C-terminal domain of dystrophin. They also suggest a negativ
e correlation between sarcolemmal expression of the dystrophin C-termi
nus and DRP expression at the sarcolemma.